We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+8.56%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$821B
AUM Growth
+$62.3B
Cap. Flow
+$23.5B
Cap. Flow %
2.87%
Top 10 Hldgs %
16.79%
Holding
7,579
New
751
Increased
3,314
Reduced
2,056
Closed
652
Avg Time Held Equity + Options
17.5 quarters
Top 10 Avg Time Held Equity + Options
16.2 quarters
Top 20 Avg Time Held Equity + Options
12.2 quarters
Avg Time Held Equity only
18.8 quarters
Top 10 Avg Time Held Equity only
16.2 quarters
Top 20 Avg Time Held Equity only
14.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.28%
2 Technology 17.17%
3 Healthcare 10.79%
4 Financials 9.36%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPYX icon
6176
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.86B
$2K ﹤0.01%
60
– –
2021 Q1
8 quarters
SRG
6177
Seritage Growth Properties
SRG
$102M
$2K ﹤0.01%
196
– –
2016 Q1
28 quarters
TWIN icon
6178
Twin Disc
TWIN
$414M
$2K ﹤0.01%
270
+258
+2,150% +$2.69K
2015 Q4
29 quarters
TYA icon
6179
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
$41.1M
$2K ﹤0.01%
+100
New +$1.58K
2023 Q1
0 quarters
VAL.WS icon
6180
Valaris Ltd Warrants
VAL.WS
$586M
– –
0
– –
2021 Q2
7 quarters
VSTM icon
6181
Verastem
VSTM
$697M
$2K ﹤0.01%
397
– –
2020 Q2
11 quarters
WIMI
6182
WiMi Hologram Cloud
WIMI
$14.1M
$2K ﹤0.01%
174
+129
+287% +$1.57K
2022 Q2
3 quarters
WIP icon
6183
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$456M
$2K ﹤0.01%
+38
New +$1.6K
2023 Q1
0 quarters
WRAP icon
6184
Wrap Technologies
WRAP
$90.8M
$2K ﹤0.01%
991
– –
2019 Q2
15 quarters
XSLV icon
6185
PUT
Invesco S&P SmallCap Low Volatility ETF
XSLV
$238M
$2K ﹤0.01%
100
-3,600,000
-100% -$163M
2022 Q1
4 quarters
YRD
6186
Yiren Digital
YRD
$83.7M
$2K ﹤0.01%
850
– –
2020 Q4
9 quarters
RPT
6187
Rithm Property Trust
RPT
$86.3M
$2K ﹤0.01%
53
+6
+13% +$285
2017 Q3
22 quarters
CSCI
6188
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$2K ﹤0.01%
208
+20
+11% +$266
2022 Q4
1 quarter
SYRS
6189
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2K ﹤0.01%
596
– –
2016 Q3
26 quarters
IBDP
6190
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$2K ﹤0.01%
95
-150
-61% -$3.68K
2019 Q4
13 quarters
BLEUW
6191
DELISTED
bleuacacia ltd Warrants
BLEUW
– –
0
– –
2022 Q2
3 quarters
TBIO
6192
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$2K ﹤0.01%
28
– –
2021 Q3
6 quarters
ALLG
6193
DELISTED
Allego N.V.
ALLG
$2K ﹤0.01%
643
-277,420
-100% -$1.02M
2022 Q3
2 quarters
TAST
6194
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2K ﹤0.01%
766
+670
+698% +$1.36K
2017 Q4
21 quarters
EDI
6195
DELISTED
Virtus Stone Harbor Emerging Markets Total Income Fund
EDI
$2K ﹤0.01%
+275
New +$1.53K
2023 Q1
0 quarters
NBW
6196
DELISTED
Neuberger Berman California Municipal Fund Inc.
NBW
$2K ﹤0.01%
+147
New +$1.65K
2023 Q1
0 quarters
CCV.WS
6197
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
– –
0
– –
2021 Q3
6 quarters
ZYNE
6198
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$2K ﹤0.01%
3,739
+3,227
+630% +$1.7K
2019 Q2
15 quarters
HEXO
6199
DELISTED
HEXO Corp. Common Shares
HEXO
$2K ﹤0.01%
373
-106
-22% -$155
2020 Q4
9 quarters
TRAQ.WS
6200
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
– –
0
– –
2022 Q2
3 quarters

Similar funds

JP Morgan Chase's Q1 2023 Portfolio in Review

As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
  • JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
  • JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
  • JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
  • JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.